BE874900A - Sels d'ornithine et d'arginine d'acides cetoniques a chaine ramifiee, et leur utilisation pour le traitement des affections hepatiques et renales - Google Patents

Sels d'ornithine et d'arginine d'acides cetoniques a chaine ramifiee, et leur utilisation pour le traitement des affections hepatiques et renales

Info

Publication number
BE874900A
BE874900A BE0/194065A BE194065A BE874900A BE 874900 A BE874900 A BE 874900A BE 0/194065 A BE0/194065 A BE 0/194065A BE 194065 A BE194065 A BE 194065A BE 874900 A BE874900 A BE 874900A
Authority
BE
Belgium
Prior art keywords
ornithine
hepatic
treatment
branched chain
arginine salts
Prior art date
Application number
BE0/194065A
Other languages
English (en)
French (fr)
Inventor
Walser M Mackensie
Original Assignee
Univ Johns Hopkins
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Johns Hopkins filed Critical Univ Johns Hopkins
Publication of BE874900A publication Critical patent/BE874900A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/185—Saturated compounds having only one carboxyl group and containing keto groups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Urology & Nephrology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
BE0/194065A 1978-03-17 1979-03-16 Sels d'ornithine et d'arginine d'acides cetoniques a chaine ramifiee, et leur utilisation pour le traitement des affections hepatiques et renales BE874900A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/887,570 US4228099A (en) 1978-03-17 1978-03-17 Ornithine and arginine salts of branched chain keto acids and uses in treatment of hepatic and renal disorders

Publications (1)

Publication Number Publication Date
BE874900A true BE874900A (fr) 1979-07-16

Family

ID=25391422

Family Applications (1)

Application Number Title Priority Date Filing Date
BE0/194065A BE874900A (fr) 1978-03-17 1979-03-16 Sels d'ornithine et d'arginine d'acides cetoniques a chaine ramifiee, et leur utilisation pour le traitement des affections hepatiques et renales

Country Status (17)

Country Link
US (1) US4228099A (sv)
JP (1) JPS5838421B2 (sv)
AU (1) AU517505B2 (sv)
BE (1) BE874900A (sv)
CA (1) CA1115729A (sv)
DE (1) DE2910221A1 (sv)
DK (1) DK153542C (sv)
ES (1) ES478710A1 (sv)
FI (1) FI72118C (sv)
FR (1) FR2419723A1 (sv)
GB (1) GB2017094B (sv)
IE (1) IE48336B1 (sv)
IT (1) IT1202904B (sv)
LU (1) LU81057A1 (sv)
NL (1) NL7902136A (sv)
NO (1) NO151119C (sv)
SE (1) SE446724B (sv)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4296127A (en) * 1979-04-18 1981-10-20 The Johns Hopkins University Mixed salts of essential or semi-essential amino acids and nitrogen-free analogs thereof
DE3438455A1 (de) * 1984-10-19 1986-06-26 Institut Dr. Ziegler, Bettingen L-lysin- und l-histidinpyruvat
US4677121A (en) * 1985-01-22 1987-06-30 The Johns Hopkins University Method of inhibiting muscle protein degradation
US4752619A (en) * 1985-12-23 1988-06-21 The Johns Hopkins University Nutritional supplement for treatment of uremia
US4871552A (en) * 1986-09-25 1989-10-03 W. R. Grace & Co.-Conn. Hydantoins as animal food supplements
US4744990A (en) * 1986-09-25 1988-05-17 W. R. Grace & Co. Hydantoins as animal food supplements
US5639731A (en) * 1987-05-22 1997-06-17 Pripps Bryggerier Ab Amino acids for the preparation of a beverage
FR2615734B1 (fr) * 1987-05-27 1989-12-01 Synthelabo Compositions pharmaceutiques contenant un melange de sels de cetoacides et d'amino-acides utiles pour le traitement de l'uremie
FR2618331B1 (fr) * 1987-07-23 1991-10-04 Synthelabo Compositions pharmaceutiques utiles pour le traitement de l'uremie
AT393079B (de) * 1989-03-06 1991-08-12 Lubec Gert Pharmazeutische verwendung von agmatin
AT393080B (de) * 1988-11-25 1991-08-12 Lubec Gert Pharmazeutische verwendung von arginin (salzen)
SE462463B (sv) * 1988-12-02 1990-07-02 Decken Alexandra V D Livs- och fodermedel innehaallande ketosyror
JP2522034B2 (ja) * 1988-12-27 1996-08-07 味の素株式会社 α−ケト酸・アミノ酸塩化合物及びその製造方法
US5210098A (en) * 1990-09-21 1993-05-11 Regents Of The University Of Minnesota Use of pyruvate to treat acute renal failure
US5234696A (en) * 1991-12-27 1993-08-10 Abbott Laboratories Method of producing tablets, tablets produced thereby, and method of treatment using same
MX9602035A (es) 1994-10-07 1997-06-28 Firmenich & Cie Composiciones y metodo para proporcionar sabor.
US5591736A (en) * 1995-07-03 1997-01-07 The Johns Hopkins University Method of retarding the progression of chronic renal failure
CA2441542A1 (en) * 2001-04-04 2002-10-17 Critical Therapeutics, Inc. Method for preventing acute renal failure
WO2006051940A1 (ja) * 2004-11-15 2006-05-18 Kyowa Hakko Kogyo Co., Ltd. Ｌ－オルニチン結晶およびその製造方法
EP2319581B1 (en) * 2004-11-26 2015-02-25 UCL Business PLC Compositions comprising ornithine and phenylacetate or phenylbutyrate for treating hepatic encephalopathy
GB0426141D0 (en) * 2004-11-26 2004-12-29 Ucl Biomedica Plc Treatment
KR20220067001A (ko) 2009-04-03 2022-05-24 오세라 테라퓨틱스, 아이엔씨. Ｌ-오르니틴 페닐 아세테이트, 및 이의 제조방법
ES2728948T3 (es) 2009-06-08 2019-10-29 Ucl Business Plc Tratamiento de la inflamación cerebral usando Fenilacetato de L-Ornitina
ES2720148T3 (es) 2010-10-06 2019-07-18 Ocera Therapeutics Inc Métodos de fabricación de fenilacetato de L-ornitina
AU2015353703B2 (en) 2014-11-24 2021-04-01 Ucl Business Plc Treatment of diseases associated with hepatic stellate cell activation using ammonia-lowering therapies
JP6990170B2 (ja) 2015-08-18 2022-01-12 オセラ セラピューティクス， インコーポレイテッド Ｌ－オルニチンをフェニルアセテートおよびフェニルブチレートのうちの少なくとも１つと組み合わせて用いる筋肉喪失の治療および予防
CN106674057A (zh) * 2015-11-09 2017-05-17 江西乐维生物药业有限公司 L-精氨酸a-酮基异己酸盐的制备方法
US11219611B2 (en) 2015-11-13 2022-01-11 Ocera Therapeutics, Inc. Formulations of L-ornithine phenylacetate
WO2017090007A1 (en) * 2015-11-29 2017-06-01 Rao M Surya Compositions and methods for the treatment of urea cycle disorders and hepatic diseases
JP7126520B2 (ja) 2017-05-11 2022-08-26 オセラ セラピューティクス， インコーポレイテッド Ｌ－オルニチンフェニルアセテートを製造する方法
US11484579B2 (en) 2017-11-29 2022-11-01 Edgar L Hull Vitamins and alpha keto acid compositions for use in a treatment program for chronic kidney disease patients
US11253496B2 (en) 2017-11-29 2022-02-22 Edgar L. Hull Alpha keto acid compositions for treating hypo-albuminemia

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA814483A (en) * 1969-06-03 Abe Kyuji L-ornithine-l-aspartate
GB1034358A (en) 1963-05-01 1966-06-29 Chugai Pharmaceutical Co Ltd Body-protein-biosynthesis promoting composition
FR1432756A (fr) 1965-02-11 1966-03-25 D Opochimiotherapie Lab Pyruvates d'amino-acides et leur procédé de préparation
US3441650A (en) * 1965-07-23 1969-04-29 Lab Jacques Logeais Sa Therapy of ammonical intoxications by di-l-ornithine alpha-ketoglutarate
DE2335215B2 (de) * 1972-07-13 1979-04-05 The Johns Hopkins University, Baltimore, Md. (V.St.A.) Verwendung einer Mischung bei der Bekämpfung von zur Urämie führenden Nierenerkrankungen
US4100161A (en) * 1974-04-15 1978-07-11 The Johns Hopkins University Promotion of protein synthesis and suppression of urea formation in the body by keto analogs of essential amino acids
US3950529A (en) * 1975-02-03 1976-04-13 Massachusetts General Hospital Amino acid formulations for patients with liver disease and method of using same

Also Published As

Publication number Publication date
IE48336B1 (en) 1984-12-12
JPS54163518A (en) 1979-12-26
FR2419723A1 (fr) 1979-10-12
NL7902136A (nl) 1979-09-19
DK153542C (da) 1988-12-05
DE2910221A1 (de) 1979-09-20
AU4515479A (en) 1979-09-20
SE446724B (sv) 1986-10-06
DK153542B (da) 1988-07-25
JPS5838421B2 (ja) 1983-08-23
FI790901A (fi) 1979-09-18
FR2419723B1 (sv) 1982-10-29
IT7921071A0 (it) 1979-03-16
NO151119C (no) 1985-02-13
FI72118B (fi) 1986-12-31
GB2017094A (en) 1979-10-03
US4228099A (en) 1980-10-14
ES478710A1 (es) 1980-01-16
CA1115729A (en) 1982-01-05
GB2017094B (en) 1982-07-07
DE2910221C2 (sv) 1988-04-28
NO151119B (no) 1984-11-05
FI72118C (sv) 1987-04-13
IE790993L (en) 1979-09-17
LU81057A1 (fr) 1979-09-07
SE7902401L (sv) 1979-10-16
NO790903L (no) 1979-09-18
AU517505B2 (en) 1981-08-06
IT1202904B (it) 1989-02-15
DK110879A (da) 1979-09-18

Similar Documents

Publication Publication Date Title
BE874900A (fr) Sels d'ornithine et d'arginine d'acides cetoniques a chaine ramifiee, et leur utilisation pour le traitement des affections hepatiques et renales
BE880830A (fr) Medicament a prise orale a action d'inhibition de l'inflammation
BE888645A (fr) Acides aminocyclopentane-alcenoiques et leurs esters, leur preparation et utilisation dans des compositions pharmaceutiques,
BE860712A (fr) Polyurethannes dispersables dans l'eau et leur procede de preparation
BE875634A (fr) Compositions pharmaceutiques et leur utilisation pour le traitement prophylactique et therapeutique de l'hyperplasie de la prostate
BE876157Q (fr) Medicament pour le traitement de l'acne
FR2347330A1 (fr) Procede de preparation d'acide methacrylique et de methacrylate de methyle
BE854416A (fr) Compositions pharmaceutiques pour le traitement des symptomes de la menopause et leur procede d'utilisation
BE891583A (fr) Acides 5,5-azobis-salicylique et ses sels utiles notamment pour le traitement des affections inflammatoires de l'intestin.
PT67352B (fr) Procedes pour la preparation d'acides thiazolidinacarboxidiques et acides en rapportes
IT1145271B (it) Apparecchio per contare e arrestare destinato all'impiego in una macchina per trattare monete
BE871860A (fr) Solution pour infusion pour le traitement de l'encephalopathie hepatique et procede pour sa preparation
BE872382A (fr) Compositions de cuivre pour application topique et leur utilisation dans le traitement des deficiences en cuivre chez les animaux
BE839533A (fr) 13,14-deshydro-11-desoxy-prostaglandines optiquement actives, leur preparation et leur emploi dans des compositions pharmaceutiques
FR2515962B1 (fr) Preparations medicamenteuses contenant un derive d'acide tetraiodothyrocarboxylique notamment pour le traitement de l'hypercholesterolemie
BE856726A (fr) Anthracyclines pour le traitement des tumeurs chez l'homme
IT1099255B (it) Dispositivo ribaltabile per l'impostazione delle righe nelle macchine da sorivere
FR2505825B1 (fr) Derives d'isoprenylamine et leur utilisation dans des compositions pharmaceutiques
FR2305412A1 (fr) Procede de preparation d'a-phenylglycines optiquement actives et composes intermediaires dans ledit procede
FR2321475A1 (fr) Esters d'acides dicarboxyliques asymetriques reactifs et leur utilisation pour l'etude des glucosides tonicardiaques
BE871029A (fr) Benzylideneaniline et ses derives, utilises pour le traitement d'inflammation chez les animaux a sang chaud
IT1119693B (it) Mutandina igienica da gettare dopo l'uso
BE853379A (fr) Procede de preparation d'acide methacrylique et de methacrylate de methyle
BE865770A (fr) Esters d'acides 1,2-halogenhydrine-carboxylique leur preparation et leur utilisation dans la preparation de cyclopropane-carbaldehydes
BE895664A (fr) Esters d'acides phenoxyphenoxypropioniques leur preparation et leur utilisation

Legal Events

Date Code Title Description
RE20 Patent expired

Owner name: THE JOHNS HOPKINS UNIVERSITY

Effective date: 19990316